The Alphabet, Virgin and Access Industries-backed cryptocurrency technology provider hiked its valuation to $5.2bn in a series C announced just five weeks after its last round.

The portfolio’s fair value rose by 21% and pre-tax profits are up 45% in the first half of Frontier IP’s fiscal year.

Helsinn is co-anchoring the second 3B Future Health Fund, which will target oncology and rare disease therapeutics startups as it seeks a $118m close.

The risk management software developer secured $17.9m in a GV-led round that included LocalGlobe and Entrepreneur First.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

DSM Venturing was among the investors in a round that will help the lab-grown meat developer widen its product range.

XtalPi and Astellas Venture Management contributed to a $45.6m round that took the drug discovery technology provider's total funding to over $60m.

Parkwalk Advisors has returned to back a $46m round for PhoreMost, weeks after the latter’s spinout Neophore attracted $21m in a series B.

The lab-grown meat developer has picked up $47m in its series A round thanks to commitments from investors including Section 32 and Agronomics.

HSBC-backed communications surveillance software developer has secured funding in a deal making Toscafund its lead investor.